Healthcare providers use continuous MRI scans performed over the course of a patient's life to monitor the progression of multiple sclerosis, where the immune system attacks the protective myelin around the nerves within the central nervous system.
MRIs are used to identify lesions or areas of scarring (sclerosis) within the central nervous system. The scarring is the result of the damage caused...
Medisafe, maker of a patient-facing app that promotes medication adherence, has completed a large international pilot in which its software improved adherence to a partnered global pharma’s cardiometabolic therapy, MobiHealthNews has learned.
Medisafe said that it was unable to disclose the identify of the international pharma partner, with whom the pilot’s success has resulted in additional...
Less than a year after the blockchain-enabled genome sequencing startup's launch, Nebula Genomics is announcing its first pharma partnership with Merck KGaA’s EMD Serono. This early partnership will come in the form of a pilot program.
As part of the deal, EMD Serono will be able to use Nebula’s network of anonymized genomic data. This new pilot is specifically zeroing in on lung cancer patients...
Merck KGaA, Darmstadt, and Silicon Valley-area big data company Palantir Technologies announced a joint venture that will focus on building an analytics and collaborative technology platform for cancer researchers.
Called Syntropy, the Boston-based effort will rely on Palantir Foundry to power its data integration platform. Any research data shared across participating groups will be transparent...
